KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Omega Healthcare Investors (OHI) over the last 17 years, with Q4 2025 value amounting to $26.7 million.

  • Omega Healthcare Investors' Capital Expenditures rose 17552.64% to $26.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $80.9 million, marking a year-over-year increase of 1723.54%. This contributed to the annual value of $80.9 million for FY2025, which is 1723.54% up from last year.
  • According to the latest figures from Q4 2025, Omega Healthcare Investors' Capital Expenditures is $26.7 million, which was up 17552.64% from $21.2 million recorded in Q3 2025.
  • Over the past 5 years, Omega Healthcare Investors' Capital Expenditures peaked at $72.6 million during Q3 2021, and registered a low of $3.1 million during Q4 2021.
  • For the 5-year period, Omega Healthcare Investors' Capital Expenditures averaged around $16.8 million, with its median value being $13.2 million (2022).
  • Per our database at Business Quant, Omega Healthcare Investors' Capital Expenditures skyrocketed by 37651.73% in 2021 and then tumbled by 8421.92% in 2022.
  • Quarter analysis of 5 years shows Omega Healthcare Investors' Capital Expenditures stood at $3.1 million in 2021, then surged by 202.45% to $9.5 million in 2022, then soared by 62.39% to $15.4 million in 2023, then plummeted by 37.2% to $9.7 million in 2024, then soared by 175.53% to $26.7 million in 2025.
  • Its Capital Expenditures was $26.7 million in Q4 2025, compared to $21.2 million in Q3 2025 and $12.8 million in Q2 2025.